Larvol Delta - Recruitment-for-the-dosimetry-phase-of-Claritys-Cu64Cu67-SARbisPSMA-theranostic-prostate-cancer-trial-completed

64/67Cu SAR-bisPSMA theranostic - Clarity Pharma

https://www.prnewswire.com/news-releases/recruitment-for-the-dosimetry-phase-of-claritys-cu-64cu-67-sar-bispsma-theranostic-prostate-cancer-trial-completed-301420839.html

Nov 10, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next